Bukwang Pharmaceutical Co., Ltd.

KRX:003000.KS

5020 (KRW) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

202320222021202020192018201720162015201420132012201120102009200820072006
Omzet 125,928.241190,909.365182,491.221169,659.754168,193.616194,223.518150,743.454138,617.594142,132.09141,687.31130,794.937147,525.248101,218.841180,621.167170,810.033161,578.385155,670.536137,523.643
Kosten van de omzet 75,882.67111,480.555106,733.23898,018.53883,944.83479,217.67470,114.60662,326.53559,287.43260,452.07860,039.21867,930.68144,960.96874,866.56472,654.63365,266.27258,847.28860,223.007
Brutowinst 50,045.57179,428.80975,757.98471,641.21584,248.782115,005.84580,628.84876,291.05982,844.65881,235.23270,755.71979,594.56756,257.873105,754.60398,155.496,312.11396,823.24877,300.636
Brutowinstmarge 0.3970.4160.4150.4220.5010.5920.5350.550.5830.5730.5410.540.5560.5860.5750.5960.6220.562
Onderzoek- en ontwikkelingskosten 38,929.20924,274.4222,464.64218,032.39617,312.22524,639.52225,067.10118,677.49314,878.75110,229.1987,242.4758,896.436,112.9296,584.1494,519.7394,703.4714,263.6812,876.391
Algemene en administratieve kosten 4,467.0545,050.2434,434.8564,475.1767,187.0066,806.8026,609.8746,540.3166,023.3895,838.7396,476.8598,247.4676,533.61212,480.1810,048.8289,365.7188,816.3687,688.259
Verkoop- en marketingkosten 17,638.50314,771.8949,059.03510,788.19215,048.25413,327.2969,885.94612,184.318,798.8929,987.8039,786.67713,493.68313,315.41610,850.33312,584.66414,366.60912,933.78413,135.718
Verkoop-, algemene en administratieve kosten 48,613.12219,822.13813,493.89115,263.36822,235.2620,134.09716,495.8218,724.62614,822.28115,826.54316,263.53621,741.15119,849.02823,330.51322,633.49223,732.32721,750.15220,823.977
Overige kosten 1,107.27535,562.88734,177.5734,317.30135,163.8735,105.426280.7248,099.4972,818.949-461.325-460.214220.44813.562-924.172-929.24-460.002267.577-242.751
Bedrijfskosten 87,542.33179,659.44470,136.10367,613.06574,711.35579,879.04572,952.9267,751.9559,556.56652,876.86247,763.18858,154.18447,747.86666,560.96459,079.70857,058.60654,363.55750,802.951
Bedrijfsresultaat -37,496.761,549.4665,621.881583.6499,537.42735,126.87,675.9288,539.10823,288.09328,358.37122,992.5321,440.3837,350.0939,193.64139,075.6939,253.50842,459.6926,497.688
Bedrijfsresultaat ratio -0.2980.0080.0310.0030.0570.1810.0510.0620.1640.20.1760.1450.0730.2170.2290.2430.2730.193
Totaal overige inkomsten en kosten netto -1,171.891-2,582.338-1,834.55-8,883.294-10,899.237155,928.8487,207.42512,492.4198,551.8321,241.2122,590.9511,794.962155.876-1,040.228-2,214.665313.0443,232.8121,139.113
Inkomen voor belasting -38,668.651-1,032.8723,787.331-8,299.645-1,361.81191,055.64714,883.35321,031.52731,839.92529,599.58325,583.48223,235.3457,505.96638,153.41336,861.02539,566.55245,692.50227,636.801
Inkomen voor belasting ratio -0.307-0.0050.021-0.049-0.0080.9840.0990.1520.2240.2090.1960.1580.0740.2110.2160.2450.2940.201
Belastingkosten -5,162.8743,215.8056,584.1281,805.0176,073.03345,398.2163,792.7265,224.0926,700.5195,983.3766,051.4476,723.4311,099.84110,759.2928,987.9098,952.11512,667.1728,089.965
Nettowinst -31,329.661-4,248.677-2,796.798-10,104.662-7,434.843145,670.05611,090.62715,807.43525,139.40523,616.20719,532.03416,511.9156,406.12527,394.12127,873.11630,880.03532,820.36519,546.836
Nettowinstmarge -0.249-0.022-0.015-0.06-0.0440.750.0740.1140.1770.1670.1490.1120.0630.1520.1630.1910.2110.142
WPA (Winst Per Aandeel) -457.67-62.07-40.85-147.23-103.652,613.89161.84222.2354.19336.67275.21233.9193.42376.05380.37423.24466.46282.67
Verwaterde WPA -457.67-62.07-40.85-147.23-103.652,613.89161.84222.2353.69336.67275.21233.9193.42376.05380.37423.24466.46282.67
EBITDA -33,204.3226,665.9959,877.846,741.44716,999.52639,238.49613,649.81426,508.0124,853.93734,035.46733,335.19332,678.56215,546.84446,561.0242,332.27645,632.76649,878.42329,638.357
EBITDA ratio -0.2640.0350.0540.040.1010.2020.0910.1910.1750.240.2550.2220.1540.2580.2480.2820.320.216